IS7893A - Perindópríl - Google Patents
PerindóprílInfo
- Publication number
- IS7893A IS7893A IS7893A IS7893A IS7893A IS 7893 A IS7893 A IS 7893A IS 7893 A IS7893 A IS 7893A IS 7893 A IS7893 A IS 7893A IS 7893 A IS7893 A IS 7893A
- Authority
- IS
- Iceland
- Prior art keywords
- perindopril
- reciprocal
- integers
- integer
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0226885A GB2395195A (en) | 2002-11-18 | 2002-11-18 | Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors |
PCT/GB2003/004981 WO2004046172A1 (en) | 2002-11-18 | 2003-11-18 | Perindopril |
Publications (1)
Publication Number | Publication Date |
---|---|
IS7893A true IS7893A (is) | 2005-06-14 |
Family
ID=9948057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS7893A IS7893A (is) | 2002-11-18 | 2005-06-14 | Perindópríl |
Country Status (28)
Country | Link |
---|---|
US (1) | US7351840B2 (is) |
EP (2) | EP1565485B1 (is) |
JP (2) | JP5110770B2 (is) |
KR (1) | KR20050075429A (is) |
CN (2) | CN100371345C (is) |
AT (2) | ATE352555T1 (is) |
AU (2) | AU2003283588B2 (is) |
BR (1) | BR0315703A (is) |
CA (1) | CA2506587A1 (is) |
DE (2) | DE60329722D1 (is) |
DK (1) | DK1565485T3 (is) |
EC (1) | ECSP055865A (is) |
ES (2) | ES2333153T3 (is) |
GB (1) | GB2395195A (is) |
GE (1) | GEP20105036B (is) |
HR (1) | HRPK20050567B3 (is) |
IL (1) | IL168660A (is) |
IS (1) | IS7893A (is) |
MA (1) | MA27567A1 (is) |
MX (1) | MXPA05005333A (is) |
NZ (1) | NZ540360A (is) |
PL (1) | PL376931A1 (is) |
PT (2) | PT1688427E (is) |
RU (1) | RU2339645C2 (is) |
SI (1) | SI1565485T1 (is) |
TN (1) | TNSN05140A1 (is) |
WO (1) | WO2004046172A1 (is) |
ZA (1) | ZA200503979B (is) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2395195A (en) * | 2002-11-18 | 2004-05-19 | Cipla Ltd | Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors |
DK1636185T3 (da) * | 2003-06-24 | 2012-05-07 | Servier Lab | Nye krystalformer af Perindopril erbumin |
GB2413128A (en) | 2004-04-13 | 2005-10-19 | Neopharma Ltd | Process for the preparation of perindopril |
SI21881A (sl) | 2004-10-15 | 2006-04-30 | Diagen, Smartno Pri Ljubljani, D.O.O. | Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine |
WO2007017893A2 (en) * | 2005-05-05 | 2007-02-15 | Arch Pharmalabs Limited | Preparation of novel crystalline form of perindopril erbumine monohydrate |
CA2615691C (en) * | 2005-07-25 | 2015-11-10 | Lek Pharmaceuticals D.D. | Process for the preparation of crystalline perindopril |
UA92613C2 (ru) * | 2005-08-12 | 2010-11-25 | Лек Фармасьютиклз Д.Д. | Способ получения кристаллической формы d эрбумина периндоприла |
JP2009505970A (ja) * | 2005-08-12 | 2009-02-12 | サンド・アクチエンゲゼルシヤフト | ペリンドプリルエルブミンの新規結晶形 |
DE102005058166A1 (de) * | 2005-12-05 | 2007-06-06 | Hexal Ag | Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren |
SI22543A (sl) | 2007-06-27 | 2008-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nove soli perindoprila |
CN101332191B (zh) * | 2008-07-10 | 2013-01-09 | 沈阳药科大学 | 一种稳定的培哚普利叔丁胺盐片剂及其制备方法 |
SI23149A (sl) | 2009-09-21 | 2011-03-31 | Silverstone Pharma | Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni |
ES2686298T3 (es) | 2010-04-20 | 2018-10-17 | Chiral Quest, Inc. | Procedimiento enantioselectivo para alaninas beta sustituidas con cicloalquenilo |
CN103110929A (zh) * | 2012-12-10 | 2013-05-22 | 江苏开元医药化工有限公司 | 米屈肼和赖诺普利的药物组合物及其制备方法 |
CN105693817B (zh) * | 2014-11-27 | 2020-06-05 | 西北大学 | 一类三肽化合物及其制备方法与应用 |
WO2016178591A2 (en) | 2015-05-05 | 2016-11-10 | Gene Predit, Sa | Genetic markers and treatment of male obesity |
CN111116709B (zh) * | 2019-12-31 | 2022-06-24 | 北京鑫开元医药科技有限公司 | 一种培哚普利制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2503155A2 (fr) * | 1980-10-02 | 1982-10-08 | Science Union & Cie | Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme |
US4508729A (en) * | 1979-12-07 | 1985-04-02 | Adir | Substituted iminodiacids, their preparation and pharmaceutical compositions containing them |
FR2620709B1 (fr) * | 1987-09-17 | 1990-09-07 | Adir | Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese |
US6395300B1 (en) * | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
JP4018854B2 (ja) * | 1999-10-28 | 2007-12-05 | 第一三共株式会社 | 抗悪性腫瘍薬 |
FR2807431B1 (fr) * | 2000-04-06 | 2002-07-19 | Adir | Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables |
FR2811318B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
FR2811320B1 (fr) | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
FR2811319B1 (fr) | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
FR2838648B1 (fr) * | 2002-04-18 | 2004-05-21 | Servier Lab | Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent |
GB2395195A (en) * | 2002-11-18 | 2004-05-19 | Cipla Ltd | Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors |
SI21881A (sl) * | 2004-10-15 | 2006-04-30 | Diagen, Smartno Pri Ljubljani, D.O.O. | Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine |
-
2002
- 2002-11-18 GB GB0226885A patent/GB2395195A/en not_active Withdrawn
-
2003
- 2003-11-18 DE DE60329722T patent/DE60329722D1/de not_active Expired - Lifetime
- 2003-11-18 ZA ZA200503979A patent/ZA200503979B/en unknown
- 2003-11-18 AT AT03775565T patent/ATE352555T1/de not_active IP Right Cessation
- 2003-11-18 WO PCT/GB2003/004981 patent/WO2004046172A1/en active IP Right Grant
- 2003-11-18 RU RU2005119162/04A patent/RU2339645C2/ru not_active IP Right Cessation
- 2003-11-18 BR BR0315703-2A patent/BR0315703A/pt not_active IP Right Cessation
- 2003-11-18 DE DE60311516T patent/DE60311516T2/de not_active Expired - Lifetime
- 2003-11-18 AU AU2003283588A patent/AU2003283588B2/en not_active Ceased
- 2003-11-18 ES ES06076083T patent/ES2333153T3/es not_active Expired - Lifetime
- 2003-11-18 PT PT06076083T patent/PT1688427E/pt unknown
- 2003-11-18 CN CNB2003801087002A patent/CN100371345C/zh not_active Expired - Fee Related
- 2003-11-18 US US10/535,187 patent/US7351840B2/en not_active Expired - Fee Related
- 2003-11-18 JP JP2004552875A patent/JP5110770B2/ja not_active Expired - Fee Related
- 2003-11-18 CA CA002506587A patent/CA2506587A1/en not_active Abandoned
- 2003-11-18 EP EP03775565A patent/EP1565485B1/en not_active Expired - Lifetime
- 2003-11-18 EP EP06076083A patent/EP1688427B1/en not_active Expired - Lifetime
- 2003-11-18 NZ NZ540360A patent/NZ540360A/en not_active IP Right Cessation
- 2003-11-18 SI SI200330676T patent/SI1565485T1/sl unknown
- 2003-11-18 PT PT03775565T patent/PT1565485E/pt unknown
- 2003-11-18 CN CNA2006101686038A patent/CN1966519A/zh active Pending
- 2003-11-18 PL PL376931A patent/PL376931A1/pl not_active IP Right Cessation
- 2003-11-18 KR KR1020057008910A patent/KR20050075429A/ko not_active Application Discontinuation
- 2003-11-18 AT AT06076083T patent/ATE445632T1/de not_active IP Right Cessation
- 2003-11-18 MX MXPA05005333A patent/MXPA05005333A/es active IP Right Grant
- 2003-11-18 DK DK03775565T patent/DK1565485T3/da active
- 2003-11-18 ES ES03775565T patent/ES2279188T3/es not_active Expired - Lifetime
-
2005
- 2005-05-18 TN TNP2005000140A patent/TNSN05140A1/en unknown
- 2005-05-18 IL IL168660A patent/IL168660A/en not_active IP Right Cessation
- 2005-06-14 IS IS7893A patent/IS7893A/is unknown
- 2005-06-16 MA MA28344A patent/MA27567A1/fr unknown
- 2005-06-17 EC EC2005005865A patent/ECSP055865A/es unknown
- 2005-06-17 HR HR20050567A patent/HRPK20050567B3/xx not_active IP Right Cessation
-
2009
- 2009-06-15 AU AU2009202389A patent/AU2009202389B2/en not_active Ceased
- 2009-12-08 GE GEAP200911591A patent/GEP20105036B/en unknown
-
2012
- 2012-07-27 JP JP2012167158A patent/JP2013006839A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS7893A (is) | Perindópríl | |
CY1113362T1 (el) | Διαρυλ-αιθερες, ως ανταγωνιστης οπιοειδους υποδοχεως | |
DE60336850D1 (en) | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren | |
DK1485359T3 (da) | Natriumkanalblokkere | |
AR051778A2 (es) | Derivados del acido dimetilaminocrotonico y procesos para supreparacion | |
CY1113657T1 (el) | Νεα παραγωγα βενζοφαινονης ή αλατα αυτων | |
ZA200309887B (en) | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents. | |
BR0109836A (pt) | Processo de sìntese de perindopril e de seus sais farmaceuticamente aceitáveis | |
DK1310502T3 (da) | Phosphonocephem-forbindelse | |
DK1385515T3 (da) | Spiropyrazole forbindelser | |
EP1420010A4 (en) | AMPHOTERE LIPID COMPOUND AND USE THEREOF | |
ATE272617T1 (de) | Sulfonamid-derivate | |
ATE431328T1 (de) | Photopolymerisierbare verbindungen | |
EA200600898A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
EA200501925A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
DK1180094T3 (da) | Kondenserede polycykliske aminosyrer som farmaceutiske midler | |
EA200601086A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
DE60207913D1 (de) | Als Matrix-Metalloproteinasehemmer verwendbare tricyclische Sulfonamide | |
NO20050834L (no) | Ny indolinforbindelse og medisinsk anvendelse derav | |
UY26778A1 (es) | Derivados de ácido heteroarilalcanoico. | |
CY1110529T1 (el) | Παρασκευη ν-υποκατεστημενων 2,7-διαλκυλο-4-υδροξυ-5-αμινο-8-αρυλοοκτανοϋλαμιδιων |